<?xml version="1.0" encoding="UTF-8"?>
<p id="para0004">COVID-19-induced proinflammatory status looks to trigger most severe SARS-CoV-2 forms.
 <xref rid="bib0002" ref-type="bibr">
  <sup>2</sup>
 </xref> Based on this assessment, many antinflammatory drugs have been proposed and used off randomized trials due to the epidemics spreading. Despite the hope and the first evidences, a real clinical utility of these molecules which mostly act on IL-6 and IL-1 (such as tocilizumab and anakinra) is still to be demonstrated, while their potential side effects are well known.
 <xref rid="bib0003" ref-type="bibr">
  <sup>3</sup>
 </xref>
</p>
